Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,121–2,128 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
InflaRx N.V. Vilobelimab (IFX-1) - (IXPLORE) ANCA-associated vasculitis (AAV) Phase 2 Trial Discontinued Intravenous Immunology
InflaRx N.V. Vilobelimab (IFX-1) Cutaneous squamous cell carcinoma (cSCC) Phase 2 Trial Discontinued Intravenous Oncology
InflaRx N.V. Vilobelimab (IFX-1) - (IXPLORE) ANCA-associated vasculitis (AAV) Phase 2 Trial Discontinued Intravenous Immunology
InflaRx N.V. Gohibic (vilobelimab) - (PANAMO) COVID-19 Phase 3 Data Released Intravenous COVID-19
InflaRx N.V. Vilobelimab (IFX-1) Pyoderma Gangrenosum (PG) Phase 3 Trial Discontinued Intravenous Immunology
InflaRx N.V. Vilobelimab (IFX-1) - (IXCHANGE) ANCA-associated Vasculitis (AAV) Phase 2 Data Released Intravenous Immunology
InflaRx N.V. Vilobelimab (IFX-1) Hidradenitis Suppurativa Phase 2 Trial Completed Intravenous Immunology: Anti-TNF
InflaRx N.V. Izicopan (INF904) Chronic Autoimmune and Inflammatory Diseases Phase 2a Data Released Oral Immunology